# Accendra Health, Inc. (ACH)

**Exchange:** NYSE  
**Sector:** Healthcare  
**Market cap:** $211M  
**Price:** $2.74 (+2.62%)

> Accendra Health, Inc. is a leading nationwide provider of products, technology, and services that support health beyond the hospital for millions of people annually. The company connects patients, providers, and insurers through innovative solutions designed to promote better health outcomes and enhance quality of life for individuals managing chronic and complex conditions. Specializing in home-based care, Accendra Health offers a broad portfolio of essentials covering diabetes management, sleep health, wound care, respiratory support, urology, and ostomy needs. Backed by the expertise of its flagship Apria and Byram brands, it reimagines post-hospital care delivery with a focus on accessibility and efficacy. Founded in 1882 and headquartered in Richmond, Virginia, the company employs approximately 23,200 people and operates within the healthcare sector, particularly in health care distribution and patient direct services. Following a strategic divestiture of its former Products & Healthcare Services business at the end of 2025, Accendra Health continues to play a pivotal role in advancing home health solutions across the United States.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $2.76B | $1.29B | $27M | -$1.10B | — |
| 2024 | $2.68B | $2.22B | -$218M | -$363M | — |
| 2023 | $2.55B | $2.13B | $133M | -$41M | — |
| 2022 | $9.96B | $1.83B | $143M | $22M | — |
| 2021 | $9.79B | $1.51B | $368M | $222M | — |
| 2020 | $8.48B | $1.28B | $204M | $30M | — |
| 2019 | $9.21B | $1.13B | $73M | -$62M | — |
| 2018 | $9.42B | $1.07B | -$352M | -$437M | — |
| 2017 | $9.32B | $1.17B | $89M | $73M | — |
| 2016 | $9.72B | $1.19B | $200M | $109M | — |
| 2015 | $9.77B | $1.21B | $200M | $103M | — |
| 2014 | $9.44B | $1.17B | $160M | $67M | — |
| 2013 | $9.07B | $1.12B | $198M | $111M | — |
| 2012 | $8.91B | $925M | $197M | $109M | — |
| 2011 | $8.63B | $858M | $204M | $115M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $2.45B | $2.91B | -$461M | $282M | — |
| 2024 | $4.66B | $4.07B | $586M | $28M | — |
| 2023 | $5.09B | $4.17B | $945M | $243M | — |
| 2022 | $5.39B | $4.44B | $967M | $69M | — |
| 2021 | $3.54B | $2.60B | $939M | $56M | — |
| 2020 | $3.34B | $2.62B | $712M | $83M | $1.03B |
| 2019 | $3.64B | $3.18B | $462M | $67M | $1.56B |
| 2018 | $3.77B | $3.26B | $518M | $66M | $1.68B |
| 2017 | $3.38B | $2.36B | $1.02B | $105M | $917M |
| 2016 | $2.72B | $1.76B | $960M | $185M | $569M |
| 2015 | $2.77B | $1.78B | $993M | $161M | $578M |
| 2014 | $2.74B | $1.74B | $991M | $57M | $614M |
| 2013 | $2.32B | $1.30B | $1.02B | $102M | $216M |
| 2012 | $2.21B | $1.24B | $973M | $98M | $218M |
| 2011 | $1.95B | $1.03B | $918M | $136M | $215M |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2024 | $161M | $170M | -$9M |
| 2023 | $741M | $172M | $568M |
| 2022 | $325M | $158M | $167M |
| 2021 | $124M | $41M | $83M |
| 2020 | $339M | $50M | $289M |
| 2019 | $166M | $42M | $124M |
| 2018 | $116M | $45M | $71M |
| 2017 | $57M | $35M | $22M |
| 2016 | $188M | $20M | $167M |
| 2015 | $270M | $21M | $250M |
| 2014 | -$4M | $48M | -$52M |
| 2013 | $141M | $28M | $112M |

Source: [CompaniesByCap](https://companiesbycap.com/company/ACH)